| 1 |
33570632 | Modulation of IL-6/STAT3 signaling axis in CD4+FOXP3- T cells represents a potential antitumor mechanism of azacitidine. | 2021 Jan 12 |
10 |
| 2 |
34555853 | Single-cell polyfunctional proteomics of CD4 cells from patients with AML predicts responses to anti-PD-1-based therapy. | 2021 Nov 23 |
1 |
| 3 |
34906298 | [miR-146a-3p is down-regulated and IL-17 is up-regulated in peripheral blood CD4+ T cells of children with neonatal sepsis]. | 2021 Dec |
2 |
| 4 |
27877174 | DNA Methyltransferase Inhibitor Promotes Human CD4+CD25hFOXP3+ Regulatory T Lymphocyte Induction under Suboptimal TCR Stimulation. | 2016 |
10 |
| 5 |
25414732 | Hypomethylation and overexpression of ITGAL (CD11a) in CD4(+) T cells in systemic sclerosis. | 2014 |
4 |
| 6 |
23242597 | The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome. | 2013 Aug |
2 |
| 7 |
22503132 | Azacitidine differentially affects CD4(pos) T-cell polarization in vitro and in vivo in high risk myelodysplastic syndromes. | 2012 Jul |
4 |
| 8 |
17947713 | Demethylation of CD40LG on the inactive X in T cells from women with lupus. | 2007 Nov 1 |
1 |
| 9 |
17213580 | [Effects of 5-azaC on methylation pattern of the perforin promoter of the perforin gene in normal human T cells]. | 2006 Dec |
2 |
| 10 |
1692774 | CD4+ cells treated with DNA methylation inhibitors induce autologous B cell differentiation. | 1990 Jun |
2 |